Preliminary applications for PLCO EEMS Round 24 will only be accepted from July 3 through August 15, 2017. If you plan to submit an EEMS Application for Biospecimens this cycle, an approved preliminary application is required. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application. The deadline for full application submission is October 2, 2017.

Information is available regarding the PLCO trial and PLCO biospecimens

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

Preliminary applications will only be accepted from May 15, 2017 through July 17, 2017. If you plan to submit a grant application this cycle, an approved preliminary grant application is required. Please see PAR Application for Biospecimens and Funding for more information. Once your preliminary grant application has been approved, you will receive a confirmation letter to accompany your grant application.

Information is available regarding the PLCO trial and PLCO biospecimens

If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

PLCO EEMS Round 23 is closed to applications. The deadline for PLCO EEMS full applications was April 3, 2017. The next round of preliminary EEMS applications will open in July 2017. If you have any questions about project feasibility and specimen availability for future EEMS rounds, please contact CDAS staff at cdas-eems@imsweb.com.

PLCO EEMS Round 23 is closed to preliminary applications. Full applications remain open for individuals with approved preliminary applications.

Full applications will only be accepted through April 3, 2017. To access your full application, you must login to CDAS. The deadline for PLCO EEMS preliminary applications was February 15, 2017. The next round of preliminary EEMS applications will open in July 2017. If you have any questions about project feasibility and specimen availability for future EEMS rounds, please contact CDAS staff at cdas-eems@imsweb.com.

Each NLST project may now receive CT images from up to 15,000 participants (of the investigator’s choice).

Investigators are encouraged to consider taking fewer than 15,000, because:

1. Many applications do not need that many.
2. The maximum total data size for 15,000 people is very high (8 terabytes).
3. The number of available screen-detected lung cancer cases (~600) and benign nodule cases (~9000) is limited.